Intrinsa Approval Status
- FDA approved: No
- Brand name: Intrinsa
- Generic name: testosterone
- Dosage form: Patch
- Company: BioSante Pharmaceuticals, Inc.
- Treatment for: Female Sexual Dysfunction
Intrinsa (testosterone transdermal patch) is an androgen intended for use in the treatment of female sexual dysfunction (FSD) in surgically menopausal women.
In December 2004, BioSante Pharmaceuticals, Inc. announced the receipt of a Not Approvable Letter from the U.S. Food and Drug Administration (FDA) advising the company that the New Drug Application (NDA) for Intrinsa had not been approved.
Development Status and FDA Approval Process for Intrinsa
|Dec 3, 2004||BioSante Pharmaceuticals Comments on FDA Advisory Committee's Decision Not to Recommend Approval of Testosterone Patch|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.